We previously found that, after immunization with vaccine Oka varicella-zoster virus, virus obtained from a single vesicle were monomorphic, and virus obtained from different individuals were heterogeneous. Here we show that virus obtained from the lungs of a patient were a mixture of vaccine Oka variants. We hypothesize that complications after immunization are unlikely to be caused by expansion of a single, biologically more virulent clone of virus that either preexists in the vaccine or develops after random mutation of different clones. We hypothesize that some clones are more trophic than others for skin.
Since 1995, a Merck vaccine using an attenuated virus derived from parental Oka varicella-zoster virus (VZV) has been licensed in the United States for the prevention of chickenpox in children [1] . As a result, between 1995 and 2000, there has been a 75% decrease in the annual incidence of chickenpox and hospitalizations, and mortality from chickenpox has decreased significantly [2, 3] . The safety record of the vaccine has also been impressive. After the administration of 140 million vaccine doses, no deaths attributable to the vaccine have been recorded [4, 5] . Although rashes and fevers are reported in up to 5% of immunized children, serious complications due to vaccine Oka are rare [4] [5] [6] , occurring primarily in children with underlying deficiencies of T cell immunity. The vaccine origin of VZV isolates from complicated cases has been established by restriction digest, either of markers that distinguish the Japanese vaccine strain from US strains [7] or of a vaccine-specific Sma1 site in open-reading frame (ORF) 62 [8] .
In contrast to the mixture of viral genotypes that is present in the vaccine preparation, we have found that viral genotypes obtained from a single vesicle of a vaccine-associated rash were monomorphic at all loci tested for single-nucleotide polymorphisms (SNPs) [9] . To date, the haplotype of each viral clone obtained from a vaccine-associated rash has been different [9] . Therefore, there is no single virulent strain within the vaccine preparation that causes rashes. Neither does the evidence support a distinct subset of vaccine genotypes as the cause of vaccine complications, including rash.
However, the heterogeneity of haplotypes could be explained by novel mutations that confer a rash-causing phenotype and that occur early and randomly during replication of vaccine Oka, such as immediately after inoculation. This situation would be analogous to the point mutations at positions 472 and 2034 that restore neurovirulence in live poliovirus vaccine type III [10] . If this scenario was correct, we would expect to find the same viral clone in every sample, including samples from multiple lesions, obtained from an individual patient with vaccine complications. At the same time, variants obtained from different individuals would be heterogeneous, which is in agreement with what we have already observed. Alternatively, complications may be determined by host immunity or genetic background. To investigate these hypotheses, we analyzed viral genotypes from a single vesicle and 2 endotracheal aspirate samples obtained from a child who developed a systemic infection after immunization with vaccine Oka.
Methods. Samples were obtained from a 13-month-old boy with partial DiGeorge syndrome and complex congenital heart disease who developed respiratory tract symptoms and 5 vesicular lesions 7 weeks after inadvertently being immunized with vaccine Oka. Polymerase chain reactions (PCRs) of 2 uncultured endotracheal aspirate samples (ETA 1 and ETA 2) obtained 4 days apart and of uncultured fluid obtained from a single vesicle were positive for the presence of vaccine Oka. The child was treated with intravenous acyclovir and cleared the virus within 7 days. Institutional review board approval was obtained for publication of this case report.
DNA extractions were performed by adding 5 mL of sample to 195 mL of 20% (wt/vol) Chelex 100 (Sigma) slurry. Chelex 100 is an ion-exchange resin that scavenges multivalent metal ions. Samples were incubated at 56ЊC for 20 min before being vortexed for 10 s and boiled for 8 min. Samples were then centrifuged at 13,249.6 g for 3 min and stored at Ϫ20ЊC. All PCRs were performed in a GeneAmp 2700 thermocycler (Perkin Elmer), initiated by hot start activation at 95ЊC for 10 min, and ended with a step of 72ЊC for 10 min before being incubated at 4ЊC
We previously identified 4 informative loci that were polymorphic for wild-type (wt) and vaccine Oka SNPs in virus strains found in vaccine-associated rashes, and strains with these polymorphisms always occurred as a mixture in the vaccine preparation [9] . In the present study, DNA from the 3 samples was amplified and directly sequenced on an ABI prism 3700 automated sequencer (Applied Biosystems) in accordance with the manufacturer's instructions. In addition, the Sma1 site, which distinguishes vaccine Oka from the wt strain, was analyzed ( figure 1A) .
Direct sequencing of the PCR product allowed us to visualize mixtures of wt and vaccine Oka SNPs. Pyrosequencing was then used to calculate the allele frequency in SNP mixtures. Nucleotides, each labeled with a different colored fluorescent dye, were incorporated into an oligonucleotide chain that was 8-15 bp in length and generated through polymerization from the 3 end of the sequencing primer. The relative amount of fluorescence was proportional to the amount of the incorporated base and the allele frequency of each polymorphism. Single-stranded DNA was purified using primers labeled with biotin at the 5 end. The biotinylated PCR product was captured with streptavidin-conjugated Sepharose and purified with a vacuum prep work station (Biotage) in accordance with the manufacturer's instructions. Pyrosequencing reactions were also performed in accordance with the manufacturer's instructions. Results. The results of the direct sequencing of the 3 samples are shown in figure 1A . Viruses obtained from the lesion were monomorphic at each locus, whereas viruses from ETA 1 and ETA 2 had a mixture of wt and vaccine Oka SNPs at all loci except the Sma1 site, which was fixed for the vaccine mutation in all cases (figure 1). In addition, viruses from ETA 1 appeared to be monomorphic at position 105724. The results of the pyrosequencing are shown in figure 1B .
Discussion. Full-length genome sequencing has identified 42 nucleotide loci where mutations have accumulated between the Biken preparation of vaccine Oka and the parental Oka strain from which it was derived [11] . Many of these mutations are also present in viruses used in the Merck and GlaxoSmithKline vaccine preparations, although subtle differences between the vaccines have been found [9, 12] . All 3 of the vaccine preparations contain mixtures of viral genotypes, and the majority of the 42 loci are polymorphic-that is, the vaccine contains a mixture of virus strains with either the parental allele or the novel mutation [9, 11, 12] . We have found only 3 lociincluding the Sma1 and Nae1 restriction sites, which are used to distinguish vaccine Oka from the wt strain [9, 13] -that are fixed for the vaccine mutation in all 3 vaccine preparations [9] . As expected, all 3 samples that were analyzed in the present study were positive for virus with the Sma1 restriction site in ORF 62, confirming that the viruses originated from vaccine Oka [8] . Both ETA 1 and ETA 2 contained a mixture of viral genotypes, whereas the viruses obtained from the lesion were monomorphic, with primarily wt SNPs at the loci studied. The results confirm previous observations that a single lesion contains a single viral genotype. The predominance of wt SNPs in the viruses obtained from the lesion is in keeping with our previous findings, which showed that, at loci where there were a mixture of SNPs in viruses used in the vaccine preparation, wt SNPs predominated in the monomorphic rash-associated viral genotypes [9] . Whether allele selection is occurring remains to be determined. The results also suggest that the respiratory tract infection was due to a mixture of viral genotypes. This is consistent with the miliary shadowing seen on chest radiographs from patients with VZV infection and supports the supposition that lung infection arises from multiple VZV lesions. We had previously concluded that the heterogeneity of rash-associated viral haplotypes obtained from infected individuals precluded the possibility that a single vaccine virus clone caused rash after immunization with Oka virus. We have now shown that multiple rash-associated virus genotypes propagate within the lung tissue of a single individual. Regrettably, we have not been able to analyze 11 skin lesion from this or any other individual. Vaccine Oka is known to replicate less well in neonatal dermal fibroblasts that in human embryo lung fibroblasts, whereas no such difference is seen with its parental Oka strain [14] . It remains possible that clonal selection of vaccine Oka occurs in the skin but not in the lungs, although our previous data suggest that no single vaccine clone is responsible for rash.
In summary, it is unlikely that vaccine complications are due to expansion of a single, biologically more virulent clone of virus that either preexists in the vaccine or develops after random mutation of different clones. The importance of selection due to host factors or more subtle characteristics of vaccine viral genotypes remains to be elucidated and is the subject of ongoing research.
